Clinical Trials on Hereditary Nonpolyposis Colon Cancer in United Kingdom

Total 866 results

Data Collection Analysis Business Management
PAS Research Services

Unknown

Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing

Endometrial Cancer | Colon Cancer

United States
National Cancer Institute (NCI)

Completed

Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers

Pancreatic Cancer | Cholangiocarcinoma | Colon Cancer | Liver Metastasis | Metastatic Colon Carcinoma

United States
Floor Backes

Terminated

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Lynch Syndrome | Recurrent Endometrial Carcinoma | Recurrent Endometrial Clear Cell Adenocarcinoma | Recurrent Endometrial Cancer | Metastatic Endometrial Cancer | Mismatch Repair Deficiency | Recurrent Uterine Corpus Carcinosarcoma

United States
VA Northern California Health Care System

Completed

Unsedated Colonoscopy for Colorectal Cancer Screening and Surveillance

Colon Polyp

United States
Ohio State University Comprehensive Cancer Center
American Cancer Society, Inc.

Completed

Ohio Patient Navigator Research Program (OPNRP)

Cervical Cancer | Breast Cancer | Rectal Cancer | Colon Cancer | Abnormal Breast Cancer Screening Tests | Abnormal Cervical Cancer Screening Tests | Abnormal Colon Cancer Screening Tests

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI); Cancer and Leukemia Group B; NSABP Foundation... and other collaborators

Terminated

Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed

Colorectal Cancer

United States
Richard Whelan
St. Luke's-Roosevelt Hospital Center

Terminated

Oral Green Tea Extract and Milk Thistle Extract to Colorectal Cancer Patients Undergoing Resection

Colon Cancer

United States
Kaiser Permanente
The University of Texas Health Science Center, Houston; Fred Hutchinson Cancer...

Completed

Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up (SOS)

Colorectal Cancer

United States
SCRI Development Innovations, LLC
GlaxoSmithKline

Completed

Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer

Colon Cancer

United States
University of California, San Francisco
National Cancer Institute (NCI); National Institutes of Health (NIH)

Not yet recruiting

IMProving Adherence to Colonoscopy Through Teams and Technology (IMPACTT)

Colorectal Cancer | Colon Cancer | Cancer Colorectal

United States
Columbia University

Not yet recruiting

PBA Use for Treatment of ATF6-/- Patients

Achromatopsia | ACHROMATOPSIA 7

United States
National Eye Institute (NEI)

Completed

CNTF Implants for CNGB3 Achromatopsia (CNTF-CNGB3-1)

Eye Disease | Achromatopsia

United States
Intuitive Surgical

Active, not recruiting

da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures

Colorectal Cancer | Benign or Malignant Rectal or Colon Tumors

United States, Korea, Republic of
Beth Israel Deaconess Medical Center
Massachusetts General Hospital; Sanofi; University of Southern California; VA Boston... and other collaborators

Completed

Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles (MicroTEC)

Advanced Pancreatic, Colon, Lung, Gastric and Ovarian Cancer

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Effectiveness and Implementation of mPATH-CRC

Cancer | Colorectal Cancer | Colon Cancer | Rectum Cancer

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer

Pancreatic Cancer | Rectal Cancer | Colon Cancer | Primary Peritoneal Cavity Cancer | Perioperative/Postoperative Complications

United States
M.D. Anderson Cancer Center
Bayer; Xencor, Inc.

Withdrawn

Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)

Colorectal Cancer | Colon Cancer | Rectum Cancer

United States
David Bajor

Active, not recruiting

CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer

Colorectal Cancer | Rectal Cancer | Solid Tumor | Colon Cancer

United States
National Cancer Institute (NCI)

Terminated

111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer

Breast Cancer | Lung Cancer | Prostate Cancer | Colon Cancer

United States
Applied Genetic Technologies Corp
National Eye Institute (NEI)

Completed

Clinical and Genetic Characterization of Individuals With Achromatopsia

Achromatopsia

United States
Norgine

Completed

Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults. (MORA)

Colorectal Cancer | Colorectal Carcinoma | Colon Cleansing

United Kingdom, Spain, Belgium, France, Germany, Italy, Poland
Ballad Health

Recruiting

Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands

Cancer Colon

United States
University of Southern California
Novartis

Unknown

Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer

Colorectal Cancer | Colon Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Genetic Study of Familial Factors in Patients With Colon Cancer

Colorectal Cancer

United States
Kimberly Engelman, PhD
National Cancer Institute (NCI)

Completed

Implementation Intentions to Promote Colon Cancer Screening in Rural Primary Care Practice

Colorectal Cancer

United States
Mt. Sinai Medical Center, Miami
Celgene Corporation

Completed

Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01) (ABX067)

Colorectal Cancer

United States
National Human Genome Research Institute (NHGRI)

Completed

Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling

Breast Cancer

United States
Indiana University

Completed

Standard Colonoscopy Versus Colonoscopy With Endocuff Vision

Colon Cancer | Colorectal Adenoma | Colorectal Polyp

United States
Synermore Biologics Co., Ltd.

Completed

Safety, Immunogenicity and Pharmacokinetics of SYN004 in Patients With Solid Tumors (SYN004_Ph_1)

Colon Cancer, Breast Cancer, Cancer of the Head and Neck

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Studying Tissue Samples From Patients With Stage II Colon Cancer Treated on Clinical Trial CLB-9581

Colorectal Cancer

United States
Stanford University

Terminated

Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer

Colorectal Cancer | Colon Cancer

United States
University of Nevada, Reno
National Institutes of Health (NIH); University of California, Davis; National...

Completed

Community Engaged Colon Cancer Screening Patient Navigator Program

ColoRectal Cancer

United States
Tufts Medical Center

Terminated

Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers

Colon Cancer

United States
Ohio State University Comprehensive Cancer Center

Completed

Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer

Rectal Cancer | Colon Cancer

United States
City of Hope Medical Center
National Cancer Institute (NCI); American Cancer Society (ACS) National Office

Completed

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

Stage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage III Renal Cell Cancer | Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional... and other conditions

United States
Asana BioSciences

Completed

A Study of ASN007 in Patients With Advanced Solid Tumors

Cancer | Neoplasm Metastasis | Pancreatic Cancer | Metastatic Cancer | Metastatic Lung Cancer | Pancreas Adenocarcinoma | Metastatic Melanoma | Colon Cancer | Colonic Neoplasms | Pancreas Cancer | Non Small Cell Lung Cancer Metastatic | Neoplasm | Pancreas Neoplasm | Metastatic Pancreatic Cancer | Metastatic Colon Cancer and other conditions

United States
Intracel

Completed

Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery

Colorectal Cancer

United States
University of Michigan
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer

Colorectal Cancer | Adenomatous Polyp of Colon | Colon Polyps

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb

Active, not recruiting

Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer

Metastatic Colorectal Cancer | Colorectal Cancer | Colon Cancer

United States
Natera, Inc.

Active, not recruiting

BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer

Colorectal Cancer | Colon Cancer

United States
University of Michigan

Completed

GI SPORE Colon Biosample Protocol

Rectal Cancer | Colon Cancer

United States
Applied Genetic Technologies Corp

Active, not recruiting

Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)

Achromatopsia

United States, Israel
NantCell, Inc.

Completed

QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer

Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Colon Cancer | Thyroid Cancer

United States
National Cancer Institute (NCI)

Completed

Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs

Non-Small Cell Lung Cancer (Stage III) | Colon Cancer (Stage II &Amp; III) | Rectal Cancer (Stage III)

United States
National Cancer Institute (NCI)

Active, not recruiting

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer

Cancer | Hereditary Neoplasms | Genetic Predisposition to Cancer | Environment

United States
University of Rochester

Completed

GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer

Colorectal Cancer

United States
University of Alabama at Birmingham

Withdrawn

Imaging With [89Zr]Panitumumab-PET/MRI in Patients With Newly Diagnosed Colorectal Cancer (Panitumumab)

Metastatic Colon Cancer

United States
Kaiser Permanente
University of Washington; Fred Hutchinson Cancer Center

Completed

Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up Supplement

Colorectal Cancer Screening

United States
M.D. Anderson Cancer Center
Mirati Therapeutics

Recruiting

Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer

Colorectal Cancer | Colon Cancer

United States
University of Illinois at Chicago
National Cancer Institute (NCI); Rush University Medical Center

Active, not recruiting

Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk

Colorectal Cancer

United States

Clinical Trials on Hereditary Nonpolyposis Colon Cancer in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations